AR218613A1 - Procedimiento para obtener derivados de la 5-sustituida 2-(4h-1,2,4-triazol-4-il)benzofenona - Google Patents

Procedimiento para obtener derivados de la 5-sustituida 2-(4h-1,2,4-triazol-4-il)benzofenona

Info

Publication number
AR218613A1
AR218613A1 AR264755A AR26475576A AR218613A1 AR 218613 A1 AR218613 A1 AR 218613A1 AR 264755 A AR264755 A AR 264755A AR 26475576 A AR26475576 A AR 26475576A AR 218613 A1 AR218613 A1 AR 218613A1
Authority
AR
Argentina
Prior art keywords
benzofenone
triazol
substituted
procedure
obtaining derivatives
Prior art date
Application number
AR264755A
Other languages
English (en)
Spanish (es)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of AR218613A1 publication Critical patent/AR218613A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/92Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR264755A 1975-12-30 1976-09-17 Procedimiento para obtener derivados de la 5-sustituida 2-(4h-1,2,4-triazol-4-il)benzofenona AR218613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
AR218613A1 true AR218613A1 (es) 1980-06-30

Family

ID=10467048

Family Applications (2)

Application Number Title Priority Date Filing Date
AR264755A AR218613A1 (es) 1975-12-30 1976-09-17 Procedimiento para obtener derivados de la 5-sustituida 2-(4h-1,2,4-triazol-4-il)benzofenona
AR268275A AR220519A1 (es) 1975-12-30 1977-06-30 Procedimiento para obtener derivados de la 5-sustituida-2-(4h-1,2,4-triazol-4-il)-benzofenona

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR268275A AR220519A1 (es) 1975-12-30 1977-06-30 Procedimiento para obtener derivados de la 5-sustituida-2-(4h-1,2,4-triazol-4-il)-benzofenona

Country Status (19)

Country Link
JP (1) JPS5283469A (ja)
AR (2) AR218613A1 (ja)
AT (1) AT350052B (ja)
AU (1) AU498113B2 (ja)
BE (1) BE846410A (ja)
CA (1) CA1126274A (ja)
CH (1) CH623315A5 (ja)
DE (1) DE2641164A1 (ja)
DK (1) DK393576A (ja)
ES (3) ES451896A1 (ja)
FR (1) FR2336930A1 (ja)
GB (1) GB1531980A (ja)
HU (1) HU172539B (ja)
IE (1) IE43841B1 (ja)
IL (1) IL50664A (ja)
NL (1) NL7610799A (ja)
NZ (1) NZ181958A (ja)
SE (1) SE7609813L (ja)
ZA (1) ZA765851B (ja)

Also Published As

Publication number Publication date
JPS5283469A (en) 1977-07-12
NZ181958A (en) 1979-03-28
ES451896A1 (es) 1978-01-16
AT350052B (de) 1979-05-10
HU172539B (hu) 1978-09-28
IL50664A0 (en) 1976-12-31
NL7610799A (nl) 1977-07-04
IL50664A (en) 1983-09-30
ES462244A1 (es) 1978-06-01
AU1749876A (en) 1978-03-16
AR220519A1 (es) 1980-11-14
ZA765851B (en) 1977-09-28
FR2336930B1 (ja) 1978-12-22
SE7609813L (sv) 1977-07-01
ATA684276A (de) 1978-10-15
GB1531980A (en) 1978-11-15
CA1126274A (en) 1982-06-22
IE43841L (en) 1977-06-30
AU498113B2 (en) 1979-02-08
DE2641164A1 (de) 1977-07-14
IE43841B1 (en) 1981-06-03
CH623315A5 (en) 1981-05-29
BE846410A (fr) 1977-01-17
FR2336930A1 (fr) 1977-07-29
ES462243A1 (es) 1978-06-01
DK393576A (da) 1977-07-01

Similar Documents

Publication Publication Date Title
ES490486A0 (es) Procedimiento para la obtencion de derivados de 4h-3,1-ben- zoxazina
AR213097A1 (es) Procedimiento para preparar derivados de la 1,4-dihidropirina
AR220525A1 (es) Procedimiento para obtener nuevos derivados de n-(2-mercapto,2-alcanoiltio,2-mercapto-alquil,2-alquiltio-alquiltio o2-alcanoiltioalquil)-acetil-prolina
ES491514A0 (es) Procedimiento para la obtencion de nuevos compuestos de 2- (pirimidinilamino)-1,3-diaza-2-cicloalqueno
AR220004A1 (es) Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona
AR221682A1 (es) Procedimiento para la preparacion de derivados de 2(imidazol-4-il,piridil-2-ilo o tiazolil-2-ilo-butil o metiltio-etilamino)-5-(1-naftil-alquilenoxi;1,3-benzodioxolil-alquilenoxi;1,4-benzodioxinilalquilenoxi;1-naftilalquilen;1,3-benzodioxolilalquilen;o 1,4-benzo dioxinilalquilen)-4-pirimidona o 4-pirimidintiona
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
ES479490A0 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
AR211938A1 (es) Procedimiento para preparar derivados de acidos 4-(3,5-diterbutil-4-hidroxi-fenilacilamino)-fenoxialquilcarboxilicos
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR225611A1 (es) Procedimiento para la obtencion de nuevos derivados 5-halogen-6-(2',4'-dihalofenoxi)-1(o 3)-sustituido-2h-1,3-dihidrobenzimidazol-2-tiona,o similares
AR218247A1 (es) Procedimiento para la obtencion de derivados de 1-(2-aminoetil)-3-(2,6-dihalofenil)-tiourea
MX144445A (es) Procedimiento para la obtencion de derivados de poliglicoleter no ionicos
AR213659A1 (es) Procedimiento para la preparacion de 2-(4-(aroil o heteroaroil)-piperazin-1-il)-4-amino-6,7-dimetoxiquinazolinas
AR211551A1 (es) Procedimiento para la produccion de nuevos 2-(2-alquil(c1-c4)-4-halofenilimino)1,3-ditiolanos
AR225415A1 (es) Procedimiento para la obtencion de nuevos derivados de pirido(2,1-b)quinazolina
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
MX4134E (es) Procedimiento para la preparacion de los compuestos 1,3-benzoditiol-2-tiona
AR217335A1 (es) Procedimiento para preparar derivados de la 2,6-difenil-3,7-dioxabiciclo-(3,3,0)-octano-4,8-diona
MX144201A (es) Procedimiento mejorado para la preparacion de ciclohexanodionas (1,3)
MX6120E (es) Procedimiento mejorado para preparar derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxipropil)-4-aril-piperazina
MX5101E (es) Procedimiento para la preparacion de 2-(2',2',2',-trihalogenoetil)-4-halogenociclobutan-1-onas
AR218613A1 (es) Procedimiento para obtener derivados de la 5-sustituida 2-(4h-1,2,4-triazol-4-il)benzofenona
MX5454E (es) Procedimiento para preparar derivados de la 1,2,4-triazin-5-ona